Fecal microbiota transplantation and emerging treatments for Clostridium difficile infection. (Q38130644)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23966282%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Fecal microbiota transplantation and emerging treatments for Clostridium difficile infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23966282%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

main subject

feces

0 references

Clostridium difficile

0 references

author

Ramy H Elshaboury

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23966282%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Krista D Gens

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23966282%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Jessica S Holt

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23966282%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

1 reference

21 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23966282%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmacy Practice

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23966282%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23966282%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23966282%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

498-505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23966282%20AND%20SRC:MED&resulttype=core&format=json

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Current status of Clostridium difficile infection epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Burden of Clostridium difficile on the healthcare system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Physician attitudes toward the use of fecal transplantation for recurrent Clostridium difficile infection in a metropolitan area

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Bacteriotherapy using fecal flora: toying with human motions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Evaluation of rumen transfaunation after surgical correction of left-sided displacement of the abomasum in cows.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Establishment of the gut microbiota in Western infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

21 January 2018

Colonization resistance

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Fecal microbiota transplantation: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Monitoring of antibiotic-induced alterations in the human intestinal microflora and detection of probiotic strains by use of terminal restriction fragment length polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

The microecology of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Durable alteration of the colonic microbiota by the administration of donor fecal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Fecal microbiota transplantation--an old therapy comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Clostridium difficile infection: new insights into management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Success of self-administered home fecal transplantation for chronic Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Fecal transplant against relapsing Clostridium difficile-associated diarrhea in 32 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Active and passive immunization against Clostridium difficile diarrhea and colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Protection against Clostridium difficile infection with broadly neutralizing antitoxin monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Treatment with monoclonal antibodies against Clostridium difficile toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Treatment with Monoclonal Antibodies againstClostridium difficileToxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Antibody against TcdB, but not TcdA, prevents development of gastrointestinal and systemic Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Clostridium difficile: development of a novel candidate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Colonization for the prevention of Clostridium difficile disease in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013499527

21 January 2018

Identifiers

DOI

10.1177/0897190013499527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23966282%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference